These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 19914431)

  • 1. The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening.
    Munck A; Houssin E; Roussey M
    J Pediatr; 2009 Dec; 155(6):928-930.e1. PubMed ID: 19914431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study.
    Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK
    Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
    Munck A; Roussey M
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U; Moatter T
    J Ayub Med Coll Abbottabad; 2006; 18(1):7-10. PubMed ID: 16773960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [National program for neonatal screening for cystic fibrosis: implementation and preliminary results].
    Navarro J; Grosskopf C; Vidailhet M; Briard ML; Farriaux JP
    J Gynecol Obstet Biol Reprod (Paris); 2003 Feb; 32(1 Suppl):1S56-60. PubMed ID: 12592165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial concordance of phenotype and microbial variation among siblings with CF.
    Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E
    Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.
    Soultan ZN; Foster MM; Newman NB; Anbar RD
    J Pediatr; 2008 Dec; 153(6):857-9. PubMed ID: 19014821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
    Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M
    Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment.
    Tluczek A; Koscik RL; Farrell PM; Rock MJ
    Pediatrics; 2005 Jun; 115(6):1692-703. PubMed ID: 15930234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis.
    Kleyn M; Korzeniewski S; Grigorescu V; Young W; Homnick D; Goldstein-Filbrun A; Schuen J; Nasr S
    Pediatr Pulmonol; 2011 Jan; 46(1):23-30. PubMed ID: 20812243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactive trypsin/DNA newborn screening for cystic fibrosis: should the R117H variant be included in CFTR mutation panels?
    Scotet V; Audrézet MP; Roussey M; Rault G; Dirou-Prigent A; Journel H; Moisan-Petit V; Storni V; Férec C
    Pediatrics; 2006 Nov; 118(5):e1523-9. PubMed ID: 17015492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
    Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis newborn screening does not delay the identification of cystic fibrosis in children with negative results.
    Maclean JE; Solomon M; Corey M; Selvadurai H
    J Cyst Fibros; 2011 Sep; 10(5):333-7. PubMed ID: 21536503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.
    Sarles J; Berthézène P; Le Louarn C; Somma C; Perini JM; Catheline M; Mirallié S; Luzet K; Roussey M; Farriaux JP; Berthelot J; Dagorn JC
    J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].
    Sermet-Gaudelus I; Munck A; Rota M; Roussey M; Feldmann D; Nguyen-Khoa T;
    Arch Pediatr; 2010 Sep; 17(9):1349-58. PubMed ID: 20719482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.